Cargando…
Investigating auranofin for the treatment of infected diabetic pressure ulcers in mice and dermal toxicity in pigs
Bacterial infection of pressure ulcers (PUs) are a notable source of hospitalization for individuals with diabetes. This study evaluated the safety profile and efficacy of auranofin to treat diabetic PUs infected with methicillin-resistant Staphylococcus aureus (MRSA). PUs were infected with MRSA in...
Autores principales: | Mohammad, Haroon, Abutaleb, Nader S., Dieterly, Alexandra M., Lyle, L. Tiffany, Seleem, Mohamed N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149385/ https://www.ncbi.nlm.nih.gov/pubmed/34035383 http://dx.doi.org/10.1038/s41598-021-90360-x |
Ejemplares similares
-
Evaluation of ebselen in resolving a methicillin-resistant Staphylococcus aureus infection of pressure ulcers in obese and diabetic mice
por: Mohammad, Haroon, et al.
Publicado: (2021) -
Auranofin Rapidly Eradicates Methicillin-resistant Staphylococcus aureus (MRSA) in an Infected Pressure Ulcer Mouse Model
por: Mohammad, Haroon, et al.
Publicado: (2020) -
Auranofin, at clinically achievable dose, protects mice and prevents recurrence from Clostridioides difficile infection
por: Abutaleb, Nader S., et al.
Publicado: (2020) -
In vivo efficacy of auranofin in a hamster model of Clostridioides difficile infection
por: Abutaleb, Nader S., et al.
Publicado: (2021) -
Repurposing auranofin as an intestinal decolonizing agent for vancomycin-resistant enterococci
por: AbdelKhalek, Ahmed, et al.
Publicado: (2018)